ELM
Pre-clinical- Indications
- Dry eye disease, Meibomian gland dysfunction
Company intelligence / Profile preview
Eyedetec Medical has developed and commercialized medical devices for the treatment of dry eye disease, including the EyeGiene® Insta-Warmth System™, which is clinically proven. Their next-generation product, the Eye Lipid Mobilizer® (ELM™), uses heat and vibration to normalize lipid oils in the tear film, addressing root causes of DED. ELM™ is being rolled out with clinical validation ongoing; it has been licensed for commercialization in Asia by Zhaoke Ophthalmology Limited.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyedetec Medical.